[1] COHEN-ROSENBLUM A, CUI Q. Osteonecrosis of the Femoral Head. Orthop Clin North Am. 2019;50(2):139-149.
[2] YUE J, WAN F, ZHANG Q, et al. Effect of glucocorticoids on miRNA expression spectrum of rat femoral head microcirculation endothelial cells. Gene. 2018;651: 126-133.
[3] WANG A, REN M, WANG J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene. 2018;671:103-109.
[4] 李时斌,赖渝,周毅,等.激素性股骨头坏死发病机制及相关信号通路的靶点效应[J].中国组织工程研究,2021,25(6):935-941.
[5] 王义生,李劲峰.股骨头坏死发病机制的研究现状与展望[J].中华实验外科杂志,2020,37(6):1001-1010.
[6] LIU LH, ZHANG QY, SUN W, et al. Corticosteroid-induced Osteonecrosis of the Femoral Head: Detection, Diagnosis, and Treatment in Earlier Stages. Chin Med J (Engl). 2017;130(21):2601-2607.
[7] KUBO T, UESHIMA K, SAITO M, et al. Clinical and basic research on steroid-induced osteonecrosis of the femoral head in Japan. J Orthop Sci. 2016;21(4):407-413.
[8] ZHAO DW, YU M, HU K, et al. Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey. Chin Med J (Engl). 2015;128(21):2843-2850.
[9] HUANG Z, CHENG C, CAO B, et al. Icariin Protects against Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats. Cell Physiol Biochem. 2018;47(2):694-706.
[10] 迟博婧,刘光源,邢磊,等. Hedgehog信号通路调控骨形成及BMSCs成骨分化的研究进展[J].中国修复重建外科杂志,2016,30(12):1545-1550.
[11] 吴修团,李文良,谢柳蓉,等. Hedgehog信号通路调节成骨细胞RANKL表达的研究进展[J].中国组织工程研究,2017,21(8):1294-1300.
[12] MA L, FENG X, WANG K, et al. Dexamethasone promotes mesenchymal stem cell apoptosis and inhibits osteogenesis by disrupting mitochondrial dynamics. FEBS Open Bio. 2019;10(2):211-220.
[13] 梁学振,许波,李刚,等.淫羊藿治疗股骨头坏死的分子机制分析[J].中国实验方剂学杂志,2018,24(14):188-194.
[14] 梁学振,骆帝,许波,等.补肾活血胶囊治疗股骨头坏死的分子机制研究[J].中华中医药杂志,2019,34(5):2188-2193.
[15] 刘金豹,李刚.靶向性钻孔减压联合辛伐他汀、补肾活血汤治疗早期激素性股骨头坏死的临床观察[J].中国中医基础医学杂志,2017,23(12):1739-1741,1766.
[16] CLARK JD, GEBHART GF, GONDER JC, et al. Special Report: The 1996 Guide for the Care and Use of Laboratory Animals. ILAR J. 1997;38(1):41-48.
[17] KILKENNY C, BROWNE WJ, CUTHILL IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage. 2012;20(4):256-260.
[18] 吴沅皞,刘维,赵文甲.血清药理学方法对药理、药效学和新药研发的贡献[J].中国组织工程研究,2018,22(24):3914-3920.
[19] 朱春胜,姜卓希,李佳静,等.中药血清谱效学研究现状概述[J].中草药,2020, 51(13):3569-3574.
[20] 卢磊,刘晓丹,张培影.中药血清药理学及血清药物化学研究进展[J].中国中医急症,2018,27(1):178-181,188.
[21] 李若飞,于春萍,兰丁璇,等.中药血清药理学实验方法与相关问题探讨[J].全科口腔医学电子杂志,2019,6(31):125,136.
[22] FANG S, LI Y, CHEN P. Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head. Drug Des Devel Ther. 2018;13:45-55.
[23] WANG SH, GOU GH, WU CC, et al. Increased COUP-TFII Expression Mediates the Differentiation Imbalance of Bone Marrow-Derived Mesenchymal Stem Cells in Femoral Head Osteonecrosis. Biomed Res Int. 2019;2019:9262430.
[24] HAN L, WANG B, WANG R, et al. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor. Stem Cell Res Ther. 2019;10(1):377.
[25] ZHOU D, CHEN YX, YIN JH, et al. Valproic acid prevents glucocorticoid‑induced osteonecrosis of the femoral head of rats. Int J Mol Med. 2018;41(6):3433-3447.
[26] SHENG HH, ZHANG GG, CHEUNG WH, et al. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development. J Orthop Surg Res. 2007;2:15.
[27] ZHANG YL, YIN JH, DING H, et al. Vitamin K2 Prevents Glucocorticoid-induced Osteonecrosis of the Femoral Head in Rats. Int J Biol Sci. 2016;12(4):347-358.
[28] SUN ZB, WANG JW, XIAO H, et al. Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study. Osteoporos Int. 2015;26(1):187-197.
[29] SHUI C, SPELSBERG TC, RIGGS BL, et al. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res. 2003;18(2):213-221.
[30] JAMES AW. Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation. Scientifica (Cairo). 2013;2013:684736.
[31] ZHUANG H, ZHANG X, ZHU C, et al. Molecular Mechanisms of PPAR-γ Governing MSC Osteogenic and Adipogenic Differentiation. Curr Stem Cell Res Ther. 2016; 11(3):255-264.
[32] XU C, WANG J, ZHU T, et al. Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation. Curr Stem Cell Res Ther. 2016;11(3):247-254.
[33] KRSTIC J, TRIVANOVIC D, OBRADOVIC H, et al. Regulation of Mesenchymal Stem Cell Differentiation by Transforming Growth Factor Beta Superfamily. Curr Protein Pept Sci. 2018;19(12):1138-1154.
[34] D’ALIMONTE I, LANNUTTI A, PIPINO C, et al. Wnt signaling behaves as a “master regulator” in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells. Stem Cell Rev Rep. 2013;9(5):642-654.
[35] JAMES AW, PANG S, ASKARINAM A, et al. Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev. 2012;21(12):2170-2178.
[36] ZHU Y, ZHANG X, GU R, et al. LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling. Stem Cell Res Ther. 2020;11(1):135.
[37] FLEURY A, HOCH L, MARTINEZ MC, et al. Hedgehog associated to microparticles inhibits adipocyte differentiation via a non-canonical pathway. Sci Rep. 2016;6: 23479.
[38] JAMES AW, LEUCHT P, LEVI B, et al. Sonic Hedgehog influences the balance of osteogenesis and adipogenesis in mouse adipose-derived stromal cells. Tissue Eng Part A. 2010;16(8):2605-2616.
[39] MAJOR LG, HOLLE AW, YOUNG JL, et al. Volume Adaptation Controls Stem Cell Mechanotransduction. ACS Appl Mater Interfaces. 2019;11(49):45520-45530.
[40] KOMORI T. Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem Cell Biol. 2018;149(4):313-323.
[41] WANG Y, PAN Z, CHEN F. Inhibition of PPARγ by bisphenol A diglycidyl ether ameliorates dexamethasone-induced osteoporosis in a mouse model. J Int Med Res. 2019;47(12):6268-6277.
[42] VALENTI MT, GARBIN U, PASINI A, et al. Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients. PLoS One. 2011;6(6):e20363.
[43] KOMATSU N, KAJIYA M, MOTOIKE S, et al. Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes. Stem Cell Res Ther. 2018; 9(1):342.
[44] CHO YL, PARK JG, KANG HJ, et al. Ginkgetin, a biflavone from Ginkgo biloba leaves, prevents adipogenesis through STAT5-mediated PPARγ and C/EBPα regulation. Pharmacol Res. 2019;139:325-336. |